These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 139505)

  • 1. Suppression of stimulating cell activity by microtubule-disrupting alkaloids.
    Ranney DF
    J Supramol Struct; 1976; 5(3):335-42. PubMed ID: 139505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microtubules and lymphocyte responses: effect of colchicine and taxol on mitogen-induced human lymphocyte activation and proliferation.
    Cuthbert JA; Shay JW
    J Cell Physiol; 1983 Aug; 116(2):127-34. PubMed ID: 6134740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of lymphocyte activation by colchicine.
    Stenzel KH; Schwartz R; Rubin AL; Novogrodsky A
    J Immunol; 1978 Sep; 121(3):863-5. PubMed ID: 211166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capacity of B cells to function as stimulators of a primary mixed leukocyte reaction.
    Krieger JI; Chesnut RW; Grey HM
    J Immunol; 1986 Nov; 137(10):3117-23. PubMed ID: 2945857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble factors in tolerance and contact sensitivity to DNFB in mice. VI. Cellular and lymphokine requirements for stimulating suppressor factor production in vitro.
    Fairchild RL; Moorhead JW
    J Immunol; 1986 Oct; 137(7):2125-31. PubMed ID: 2944949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1 -one: protection by Bcl-2 and Bcl-X(L) and cell cycle arrest.
    Gajate C; Barasoain I; Andreu JM; Mollinedo F
    Cancer Res; 2000 May; 60(10):2651-9. PubMed ID: 10825137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of human cell-mediated cytotoxicity. III. Dependence of natural killing on microtubule and microfilament integrity.
    Katz P; Zaytoun AM; Lee JH
    J Immunol; 1982 Dec; 129(6):2816-25. PubMed ID: 6890568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine-sensitive structures and lymphocyte activation.
    Greene WC; Parker CM; Parker CW
    J Immunol; 1976 Sep; 117(3):1015-22. PubMed ID: 956646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of taxol on microtubule organization in mouse splenic lymphocytes and on response to mitogenic stimulation.
    Brown DL; Little JE; Chaly N; Schweitzer I; Paulin-Levasseur M
    Eur J Cell Biol; 1985 May; 37():130-9. PubMed ID: 2863144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of microtubule-active agents with nicotinic acetylcholine receptors. Relationship to their inhibition of catecholamine secretion by adrenal chromaffin cells.
    McKay DB; Aronstam RS; Schneider AS
    Mol Pharmacol; 1985 Jul; 28(1):10-6. PubMed ID: 2410767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autologous mixed lymphocyte culture (AMLC)].
    Volk HD; Grunow R
    Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells.
    Shtil AA; Mandlekar S; Yu R; Walter RJ; Hagen K; Tan TH; Roninson IB; Kong AN
    Oncogene; 1999 Jan; 18(2):377-84. PubMed ID: 9927194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production.
    Woody JN; Ahmed A; Knudsen RC; Strong DM; Sell KW
    J Clin Invest; 1975 May; 55(5):956-66. PubMed ID: 1091657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of receptor-mediated shape change in astroglial cells.
    Shain W; Bausback D; Fiero A; Madelian V; Turner JN
    Glia; 1992; 5(3):223-38. PubMed ID: 1350270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of concanavalin A-induced suppressor cells in human MLR: differential effects on primary MLR, secondary MLR, and memory cell precursors.
    Goeken NE
    J Immunol; 1982 May; 128(5):2081-6. PubMed ID: 6460816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reduction in energy-dependent amino acid transport by microtubular inhibitors in Ehrlich ascites tumor cells.
    Fyfe MJ; Loftfield S; Goldman ID
    J Cell Physiol; 1975 Oct; 86(2 Pt 1):201-11. PubMed ID: 1194361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of the presentation of minor lymphocyte-stimulating determinants. II. Differing non-MHC control of super-stimulatory and more poorly stimulatory Mls phenotypes.
    Ryan JJ; LeJeune HB; Mond JJ; Finkelman FD
    J Immunol; 1990 Apr; 144(7):2506-17. PubMed ID: 2138649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human lung tissue and anaphylaxis. Evidence that cyclic nucleotides modulate the immunologic release of mediators through effects on microtubular assembly.
    Kaliner M
    J Clin Invest; 1977 Oct; 60(4):951-9. PubMed ID: 197128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.